Sanofi News

6-K: 15.7% Sales Growth Boosted by Earlier-Than-Anticipated Vaccine Sales; 2024 Business Eps Guidance Raised Due to Strong Business Performance

Oct 26 00:42

6-K: Sanofi Reports Strong Second Quarter Results with 10% Sales Growth; 2024 Guidance Upgraded

Jul 25 23:48

6-K: 2024 Half-Year Financial Report

Jul 25 22:29

Sanofi | 6-K: Colletion of Recent Announcements

May 3 03:56

Sanofi | 6-K: Sanofi Q1 Robust 7% Sales Growth Driven by Launches, Underpins Full-Year Guidance

Apr 25 22:55

Sanofi | 20-F: FY2023 Annual Report

Feb 24 00:20

Sanofi | 6-K: Sanofi Delivers Solid Sales and Business EPS Growth at CER Amidst Successful Product Launches and Advancements in Immunology Pipeline

Feb 1 22:46

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 29, 2023 03:35

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 28, 2023 19:00

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Jun 2, 2023 22:53

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Apr 27, 2023 23:39

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Mar 13, 2023 19:38

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 25, 2023 06:20

Sanofi | 20-F: FY2022 Annual Report

Feb 24, 2023 23:25

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Feb 4, 2023 00:40

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Oct 28, 2022 23:16

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Sep 22, 2022 21:49

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 28, 2022 22:12

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

Jul 28, 2022 18:17

Sanofi | 6-K: Report of foreign private issuer (related to financial reporting)

May 18, 2022 03:20